These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 997468)

  • 21. [Disposition to lung diseases caused by atypical mycobacteria; treatment results and late results].
    Krebs A
    Z Tuberk Erkr Thoraxorg; 1967; 127(1):133-40. PubMed ID: 5632190
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therizidone in the treatment of chronic pulmonary tuberculosis. (Report of clinical trials)].
    Meo G; Cernetti B; Zordan M
    G Ital Mal Torace; 1969; 23(3):135-48. PubMed ID: 5355950
    [No Abstract]   [Full Text] [Related]  

  • 23. [Efficacy of a long-term antibacterial therapy in patients with chronic destructive pulmonary tuberculosis at a rural antituberculous dispensary].
    Bokhonok VS
    Probl Tuberk; 1972; 50(2):17-9. PubMed ID: 5016414
    [No Abstract]   [Full Text] [Related]  

  • 24. [Multiple chemo-antibiotic therapy in pulmonary tuberculosis. Clinical and bacteriological results on 136 treated patients].
    Boccitto G; De Ritis GC; Salvati F; Termine A
    Clin Ter; 1969 Mar; 48(5):453-64. PubMed ID: 5386429
    [No Abstract]   [Full Text] [Related]  

  • 25. [Reactions of lung tissue and sequelae occurring in lungs during treatment of chronic pulmonary tuberculosis. 3. Pulmonary aspergillosis].
    Szymańska D
    Gruzlica; 1973 Mar; 41(3):267-72. PubMed ID: 4572206
    [No Abstract]   [Full Text] [Related]  

  • 26. [Chemotherapy effectiveness in chronic and hyperchronic forms of destructive pulmonary tuberculosis].
    Kartoziia LS
    Probl Tuberk; 1981 Apr; (4):32-5. PubMed ID: 7255373
    [No Abstract]   [Full Text] [Related]  

  • 27. [Epidemiologic aspects of resistance to ATA (Antitubercular Agents)].
    Zrilić V; Muzikravić T
    Plucne Bolesti Tuberk; 1974; 26 Suppl 2():29-37. PubMed ID: 4216919
    [No Abstract]   [Full Text] [Related]  

  • 28. [1st observations on the activity of the oral Rifampicin in the treatment of chronic pulmonary tuberculosis].
    Daddi G; Cornia G; Grassi C; Perna G; Scarpazza G
    G Ital Mal Torace; 1967; 21(3):131-6. PubMed ID: 5604472
    [No Abstract]   [Full Text] [Related]  

  • 29. [Evaluation of the treatment with reserve drugs of patients excreting drug resistant bacilli, as one solution to the problem of the so-called "chronic cases"].
    Pieniazek J; Martyniak-Murczkiewicz Z; Schnotale J; Waligóra-Antczak R
    Gruzlica; 1968 Oct; 36(10):1050-2. PubMed ID: 5710087
    [No Abstract]   [Full Text] [Related]  

  • 30. Medical and social aspects of chronic pulmonary tuberculosis in Finland.
    Tani P
    Scand J Respir Dis Suppl; 1970; 72():93-105. PubMed ID: 5273228
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparative characteristics of the use of rifadin and ethambutol in the complex treatment of patients with fibro-cavernous pulmonary tuberculosis].
    Tarasova EF; Sagalovich VIa
    Probl Tuberk; 1974; (12):26-30. PubMed ID: 4445131
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effectiveness of ethambutol in chronic pulmonary tuberculosis].
    Golli V; Stefanin E; Chiper P; Stefănescu I; Popescu-Crivina IM; Anghel E; Kosinski E; Daha A; Kosinski M; Floricel N
    Ftiziologia; 1972; 21(5):489-94. PubMed ID: 4632131
    [No Abstract]   [Full Text] [Related]  

  • 33. [Incidence of electrocardiographic symptoms of chronic non-specific broncho-pulmonary diseases in patients with tuberculosis].
    Oklek K
    Gruzlica; 1970; 38(7):673-80. PubMed ID: 5453676
    [No Abstract]   [Full Text] [Related]  

  • 34. [New experiences with 4-4' diisomayloxythiocarbanilide (D.A.T.C.) in association with other antitubercular drugs in chronic pulmonary tuberculosis].
    Frati HI
    Rev Sanid Milit Argent; 1967; 66(1):71-4. PubMed ID: 5629062
    [No Abstract]   [Full Text] [Related]  

  • 35. [Chemo-antibiotic resis tance and clinicoradiologic patterns of the disease in patients with chronic pulmonary tuberculosis].
    Giura R
    G Ital Mal Torace; 1967; 21(4):205-9. PubMed ID: 4970415
    [No Abstract]   [Full Text] [Related]  

  • 36. [Late results of treatment of chronic pulmonary tuberculosis with ethambutol and capreomycin].
    Polaczek E; Lachowicz E; Araszkiewicz W; Kozakow H; Kazimierczak A; Pszonicka A; Potworowska M; Janowiec M; Styszewska H; Klimkiewicz H; Grabowska R
    Gruzlica; 1973 Jul; 41(7):789-93. PubMed ID: 4125930
    [No Abstract]   [Full Text] [Related]  

  • 37. [Combined treatment with capreomycin, ethambutol and rifampizin in chronic open pulmonary tuberculosis].
    Virchow C; Flemming J
    Beitr Klin Erforsch Tuberk Lungenkr; 1969; 140(1):40-6. PubMed ID: 5824389
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of patients with destructive pulmonary tuberculosis by the intracavitary administration of drugs].
    Mŏkhin EP; Gimaddinov RZh
    Probl Tuberk; 1985; (2):41-3. PubMed ID: 4001094
    [No Abstract]   [Full Text] [Related]  

  • 39. [Drip endobronchial administration of complex antitubercular preparations in the treatment of destructive pulmonary tuberculosis].
    Patrikeev GA
    Probl Tuberk; 1975; (6):26-9. PubMed ID: 1215344
    [No Abstract]   [Full Text] [Related]  

  • 40. [Characteristics of the course of pulmonary tuberculosis combined with chronic opisthorchiasis].
    Strelis AK; Zadorozhnyĭ AI; Kuz'michev MA; Limberg VR
    Med Parazitol (Mosk); 1985; (5):11-3. PubMed ID: 4088131
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.